[1] Mutahir Z, Clausen AR, Andersson KM,et al. Thymidine kinase 1 regulatory fine-tuning through tetramer formation[J].FEBS J,2013, 280(6):1531-1541. [2] Felix K, Hinz U, Dobiasch S, et al. Preoperative serum thymidine kinase activity as novel monitoring, prognostic, and predictive biomarker in pancreatic cancer[J].Pancreas,2018, 47(1):72-79. [3] Fujimoto T, Hirokawa M, Ota H, et al. Characteristic sonographic features of cribriform papillary thyroid carcinoma for differentiation from other thyroid nodules [J].J Med Ultrason (2001),2015, 42(1):83-87. [4] Heck K, Happel C, Grünwald F, et al. Percutaneous microwave abla tion of thyroid nodules: effects on thyroid function and antibodies[J].Int J Hyperthermia,2015, 31(5): 560-567. [5] Agrawal C, Guthrie L, Sturm MS, et al.Comparison of Thyroid Nodule Prevalence by Ultrasound in Childhood Cancer Survivors With and Without Thyroid Radiation Exposure [J].J Pediatr Hematol Oncol,2016, 38(1): 43-48. [6] Chen YL, Eriksson S, Chang ZF. Regulation and functional contribution of thymidine kinase 1 in repair of DNA damage[J].Biol Chem,2010, 285(35):27327-27335. [7] 程田,唐振林.胸苷激酶和甲状腺球蛋白检测对鉴别甲状腺结节良恶性的价值[J].中国肿瘤临床, 2018, 45(9):445-448. [8] 李芳.血清胸苷激酶检测在甲状腺疾病鉴别诊断中的应用价值 [J].广西医科大学学报, 2015, 32(5)728-730. [9] Lee SH, Baek JS, Lee JY, et al. Predictive factors of malignancy in thyroid nodules with a cytological diagnosis of follicular neoplasm[J].Endocr Pathol,2013, 24(4): 177-183.
2019, Vol. 36 
